US 11,110,112 B2Granted

Methods for the use of 5'-adenosine diphosphate ribose (ADPR)

AssigneeInvirsa, Inc.

InventorRobert Shalwitz

Life of this patent

Estimating the term…

Abstract

The present invention is directed to methods for the use of 5′-adenosine diphosphate ribose (ADPR), and compositions thereof, for treating, managing, or preventing adenovirus-related diseases or conditions, eye disorders, cancer, or diseases or conditions caused by infection, inflammation, or physical, chemical, thermal, or radiation injuries.

Claims2

Dependent claims

A compound having the formula:

or a tautomer, stereoisomer, or isotopologue thereof.

Dependencies are inferred from the claim text.

Facts

Application: 15/999,269Filed 17 Feb 2017 · us provisional application
Priority: 18 Feb 2016
Published: US 2020/0330498 A122 Oct 2020
Granted: 7 Sep 2021
Term ends: Not estimatedThe source records don’t support an estimate.

Classification22 codes

A61K 31/7076
Containing condensed or non-condensed pyrimidines: containing purines, e.g. adenosine, adenylic acid
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 31/522
Purines, e.g. adenine: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
A61K 31/675
Phosphorus compounds: having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Family

Application62/296,665Us provisional application · filed 18 Feb 2016
Application62/428,721Us provisional application · filed 1 Dec 2016
US 2020/0330498 A1Pre-grant publication · published 22 Oct 2020
US 11,110,112 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results